nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—ALB—focal segmental glomerulosclerosis	0.402	1	CbGaD
Ketoprofen—SLCO1A2—Cyclosporine—focal segmental glomerulosclerosis	0.174	0.438	CbGbCtD
Ketoprofen—SLC22A6—Cyclosporine—focal segmental glomerulosclerosis	0.105	0.266	CbGbCtD
Ketoprofen—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.0694	0.175	CbGbCtD
Ketoprofen—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.0484	0.122	CbGbCtD
Ketoprofen—SLC22A8—nephron—focal segmental glomerulosclerosis	0.00865	0.15	CbGeAlD
Ketoprofen—Septicemia—Cyclosporine—focal segmental glomerulosclerosis	0.00623	0.0811	CcSEcCtD
Ketoprofen—PTGS2—nephron—focal segmental glomerulosclerosis	0.00491	0.0849	CbGeAlD
Ketoprofen—CXCL8—nephron tubule—focal segmental glomerulosclerosis	0.004	0.0691	CbGeAlD
Ketoprofen—Stomach ache—Cyclosporine—focal segmental glomerulosclerosis	0.00333	0.0433	CcSEcCtD
Ketoprofen—SLC22A11—nephron tubule—focal segmental glomerulosclerosis	0.00331	0.0573	CbGeAlD
Ketoprofen—SLC22A6—nephron tubule—focal segmental glomerulosclerosis	0.00312	0.054	CbGeAlD
Ketoprofen—SLC22A11—kidney—focal segmental glomerulosclerosis	0.00291	0.0503	CbGeAlD
Ketoprofen—SLC22A7—kidney—focal segmental glomerulosclerosis	0.00284	0.0491	CbGeAlD
Ketoprofen—SLC22A11—cortex of kidney—focal segmental glomerulosclerosis	0.00283	0.049	CbGeAlD
Ketoprofen—SLC22A7—cortex of kidney—focal segmental glomerulosclerosis	0.00277	0.0478	CbGeAlD
Ketoprofen—SLC22A6—cortex of kidney—focal segmental glomerulosclerosis	0.00267	0.0462	CbGeAlD
Ketoprofen—PTGS1—endothelium—focal segmental glomerulosclerosis	0.00242	0.0418	CbGeAlD
Ketoprofen—Gastrointestinal symptom NOS—Cyclosporine—focal segmental glomerulosclerosis	0.0024	0.0313	CcSEcCtD
Ketoprofen—PTGS2—endothelium—focal segmental glomerulosclerosis	0.00231	0.04	CbGeAlD
Ketoprofen—Peptic ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00211	0.0276	CcSEcCtD
Ketoprofen—ABCC4—nephron tubule—focal segmental glomerulosclerosis	0.00188	0.0326	CbGeAlD
Ketoprofen—SLC22A8—nephron tubule—focal segmental glomerulosclerosis	0.00187	0.0323	CbGeAlD
Ketoprofen—SLCO1A2—kidney—focal segmental glomerulosclerosis	0.00172	0.0297	CbGeAlD
Ketoprofen—ABCC4—kidney—focal segmental glomerulosclerosis	0.00165	0.0286	CbGeAlD
Ketoprofen—SLC22A8—kidney—focal segmental glomerulosclerosis	0.00164	0.0284	CbGeAlD
Ketoprofen—ABCC4—cortex of kidney—focal segmental glomerulosclerosis	0.00161	0.0279	CbGeAlD
Ketoprofen—SLC22A8—cortex of kidney—focal segmental glomerulosclerosis	0.0016	0.0276	CbGeAlD
Ketoprofen—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.0204	CcSEcCtD
Ketoprofen—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.0193	CcSEcCtD
Ketoprofen—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.0181	CcSEcCtD
Ketoprofen—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.0178	CcSEcCtD
Ketoprofen—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.0174	CcSEcCtD
Ketoprofen—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.0165	CcSEcCtD
Ketoprofen—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.016	CcSEcCtD
Ketoprofen—CYP2C8—kidney—focal segmental glomerulosclerosis	0.0012	0.0208	CbGeAlD
Ketoprofen—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.0154	CcSEcCtD
Ketoprofen—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.0153	CcSEcCtD
Ketoprofen—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.0149	CcSEcCtD
Ketoprofen—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.0149	CcSEcCtD
Ketoprofen—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.0149	CcSEcCtD
Ketoprofen—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.0148	CcSEcCtD
Ketoprofen—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.0142	CcSEcCtD
Ketoprofen—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.0141	CcSEcCtD
Ketoprofen—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.014	CcSEcCtD
Ketoprofen—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.014	CcSEcCtD
Ketoprofen—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.0139	CcSEcCtD
Ketoprofen—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.0137	CcSEcCtD
Ketoprofen—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.0132	CcSEcCtD
Ketoprofen—PTGS1—kidney—focal segmental glomerulosclerosis	0.000974	0.0168	CbGeAlD
Ketoprofen—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.000937	0.0122	CcSEcCtD
Ketoprofen—PTGS2—kidney—focal segmental glomerulosclerosis	0.000931	0.0161	CbGeAlD
Ketoprofen—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.000908	0.0118	CcSEcCtD
Ketoprofen—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.000872	0.0114	CcSEcCtD
Ketoprofen—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00087	0.0113	CcSEcCtD
Ketoprofen—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.000807	0.0105	CcSEcCtD
Ketoprofen—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.000802	0.0105	CcSEcCtD
Ketoprofen—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00078	0.0102	CcSEcCtD
Ketoprofen—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000777	0.0101	CcSEcCtD
Ketoprofen—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.000775	0.0101	CcSEcCtD
Ketoprofen—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000771	0.01	CcSEcCtD
Ketoprofen—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.000771	0.01	CcSEcCtD
Ketoprofen—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000769	0.01	CcSEcCtD
Ketoprofen—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.000754	0.00982	CcSEcCtD
Ketoprofen—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.000746	0.00972	CcSEcCtD
Ketoprofen—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000712	0.00927	CcSEcCtD
Ketoprofen—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00071	0.00925	CcSEcCtD
Ketoprofen—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000705	0.00918	CcSEcCtD
Ketoprofen—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000684	0.00891	CcSEcCtD
Ketoprofen—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000662	0.00862	CcSEcCtD
Ketoprofen—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000659	0.00858	CcSEcCtD
Ketoprofen—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000637	0.0083	CcSEcCtD
Ketoprofen—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000634	0.00826	CcSEcCtD
Ketoprofen—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000627	0.00817	CcSEcCtD
Ketoprofen—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000609	0.00793	CcSEcCtD
Ketoprofen—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000606	0.0079	CcSEcCtD
Ketoprofen—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000605	0.00789	CcSEcCtD
Ketoprofen—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.0006	0.00782	CcSEcCtD
Ketoprofen—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000573	0.00747	CcSEcCtD
Ketoprofen—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000571	0.00744	CcSEcCtD
Ketoprofen—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000565	0.00736	CcSEcCtD
Ketoprofen—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000557	0.00726	CcSEcCtD
Ketoprofen—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000555	0.00723	CcSEcCtD
Ketoprofen—Magnesium salicylate—ALB—focal segmental glomerulosclerosis	0.000549	0.254	CrCbGaD
Ketoprofen—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000535	0.00698	CcSEcCtD
Ketoprofen—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000534	0.00695	CcSEcCtD
Ketoprofen—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000526	0.00686	CcSEcCtD
Ketoprofen—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000524	0.00683	CcSEcCtD
Ketoprofen—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00052	0.00677	CcSEcCtD
Ketoprofen—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000515	0.0067	CcSEcCtD
Ketoprofen—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000509	0.00663	CcSEcCtD
Ketoprofen—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000504	0.00657	CcSEcCtD
Ketoprofen—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000504	0.00657	CcSEcCtD
Ketoprofen—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000501	0.00653	CcSEcCtD
Ketoprofen—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000494	0.00643	CcSEcCtD
Ketoprofen—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000488	0.00635	CcSEcCtD
Ketoprofen—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000481	0.00626	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00046	0.00599	CcSEcCtD
Ketoprofen—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000456	0.00594	CcSEcCtD
Ketoprofen—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000453	0.0059	CcSEcCtD
Ketoprofen—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00045	0.00586	CcSEcCtD
Ketoprofen—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000448	0.00584	CcSEcCtD
Ketoprofen—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000444	0.00578	CcSEcCtD
Ketoprofen—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000438	0.00571	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000435	0.00567	CcSEcCtD
Ketoprofen—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000435	0.00567	CcSEcCtD
Ketoprofen—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000431	0.00562	CcSEcCtD
Ketoprofen—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000416	0.00542	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000412	0.00537	CcSEcCtD
Ketoprofen—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000401	0.00522	CcSEcCtD
Ketoprofen—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000399	0.00519	CcSEcCtD
Ketoprofen—Fenoprofen—ALB—focal segmental glomerulosclerosis	0.000386	0.178	CrCbGaD
Ketoprofen—CXCR1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.000373	0.00585	CbGpPWpGaD
Ketoprofen—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000372	0.00484	CcSEcCtD
Ketoprofen—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000362	0.00471	CcSEcCtD
Ketoprofen—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—focal segmental glomerulosclerosis	0.00036	0.00564	CbGpPWpGaD
Ketoprofen—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000357	0.00465	CcSEcCtD
Ketoprofen—CXCL8—ATF-2 transcription factor network—MMP2—focal segmental glomerulosclerosis	0.000356	0.00559	CbGpPWpGaD
Ketoprofen—ALB—Lipid and lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.000352	0.00552	CbGpPWpGaD
Ketoprofen—Naproxen—ALB—focal segmental glomerulosclerosis	0.000351	0.162	CrCbGaD
Ketoprofen—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000345	0.0045	CcSEcCtD
Ketoprofen—PTGS2—Spinal Cord Injury—COL4A1—focal segmental glomerulosclerosis	0.000342	0.00536	CbGpPWpGaD
Ketoprofen—CXCL8—LPA receptor mediated events—MMP2—focal segmental glomerulosclerosis	0.000334	0.00523	CbGpPWpGaD
Ketoprofen—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000334	0.00435	CcSEcCtD
Ketoprofen—CXCR1—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.000333	0.00523	CbGpPWpGaD
Ketoprofen—Phenprocoumon—ALB—focal segmental glomerulosclerosis	0.000333	0.154	CrCbGaD
Ketoprofen—CXCL8—Peptide ligand-binding receptors—AGTR2—focal segmental glomerulosclerosis	0.00033	0.00517	CbGpPWpGaD
Ketoprofen—CXCL8—Syndecan-2-mediated signaling events—TGFB1—focal segmental glomerulosclerosis	0.000328	0.00514	CbGpPWpGaD
Ketoprofen—CXCL8—Toll-like Receptor Signaling Pathway—SPP1—focal segmental glomerulosclerosis	0.000325	0.00509	CbGpPWpGaD
Ketoprofen—ALB—Lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	0.000323	0.00507	CbGpPWpGaD
Ketoprofen—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000321	0.00418	CcSEcCtD
Ketoprofen—CXCR1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.000319	0.00501	CbGpPWpGaD
Ketoprofen—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000318	0.00414	CcSEcCtD
Ketoprofen—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000318	0.00414	CcSEcCtD
Ketoprofen—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000316	0.00412	CcSEcCtD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—PCNA—focal segmental glomerulosclerosis	0.000311	0.00488	CbGpPWpGaD
Ketoprofen—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.0003	0.0039	CcSEcCtD
Ketoprofen—Warfarin—ALB—focal segmental glomerulosclerosis	0.000295	0.136	CrCbGaD
Ketoprofen—CXCR1—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000287	0.0045	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	0.000284	0.00445	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—focal segmental glomerulosclerosis	0.000279	0.00438	CbGpPWpGaD
Ketoprofen—CXCL8—G alpha (i) signalling events—AGTR2—focal segmental glomerulosclerosis	0.000278	0.00436	CbGpPWpGaD
Ketoprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—focal segmental glomerulosclerosis	0.000276	0.00433	CbGpPWpGaD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—focal segmental glomerulosclerosis	0.000271	0.00424	CbGpPWpGaD
Ketoprofen—CXCR1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.000265	0.00416	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—FN1—focal segmental glomerulosclerosis	0.000265	0.00415	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet degranulation—FN1—focal segmental glomerulosclerosis	0.000258	0.00404	CbGpPWpGaD
Ketoprofen—CXCL8—IL-3 Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.000256	0.00401	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of toll-like receptor signaling pathway—SPP1—focal segmental glomerulosclerosis	0.000253	0.00398	CbGpPWpGaD
Ketoprofen—CXCL8—Peptide ligand-binding receptors—AGTR1—focal segmental glomerulosclerosis	0.000253	0.00397	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000253	0.00397	CbGpPWpGaD
Ketoprofen—Flurbiprofen—ALB—focal segmental glomerulosclerosis	0.000252	0.116	CrCbGaD
Ketoprofen—CXCL8—LPA receptor mediated events—MMP9—focal segmental glomerulosclerosis	0.000251	0.00393	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.000247	0.00388	CbGpPWpGaD
Ketoprofen—ABCC4—Response to elevated platelet cytosolic Ca2+—FN1—focal segmental glomerulosclerosis	0.000246	0.00385	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000243	0.00381	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	0.000238	0.00374	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—MMP9—focal segmental glomerulosclerosis	0.000233	0.00366	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	0.00023	0.00361	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.000221	0.00347	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—SERPINE1—focal segmental glomerulosclerosis	0.00022	0.00346	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	0.000217	0.0034	CbGpPWpGaD
Ketoprofen—ALB—Lipid and lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	0.000215	0.00337	CbGpPWpGaD
Ketoprofen—CXCL8—Peptide ligand-binding receptors—EDN1—focal segmental glomerulosclerosis	0.000215	0.00337	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet degranulation—SERPINE1—focal segmental glomerulosclerosis	0.000215	0.00336	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet degranulation—ALB—focal segmental glomerulosclerosis	0.000214	0.00336	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000212	0.00332	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000211	0.00331	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—focal segmental glomerulosclerosis	0.00021	0.00329	CbGpPWpGaD
Ketoprofen—ABCC4—Response to elevated platelet cytosolic Ca2+—SERPINE1—focal segmental glomerulosclerosis	0.000204	0.00321	CbGpPWpGaD
Ketoprofen—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—focal segmental glomerulosclerosis	0.000204	0.0032	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000202	0.00317	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000199	0.00312	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000193	0.00302	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—TGFB1—focal segmental glomerulosclerosis	0.000192	0.00302	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	0.000192	0.00302	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000191	0.003	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000183	0.00287	CbGpPWpGaD
Ketoprofen—CXCL8—Peptide ligand-binding receptors—AGT—focal segmental glomerulosclerosis	0.000178	0.0028	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000177	0.00278	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	0.000175	0.00274	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00017	0.00267	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.000168	0.00264	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000167	0.00262	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.000165	0.00259	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000162	0.00254	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000161	0.00252	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000155	0.00243	CbGpPWpGaD
Ketoprofen—CXCL8—Corticotropin-releasing hormone—TGFB1—focal segmental glomerulosclerosis	0.000155	0.00242	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	0.000154	0.00241	CbGpPWpGaD
Ketoprofen—CXCL8—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.00015	0.00236	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000147	0.00231	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.000144	0.00226	CbGpPWpGaD
Ketoprofen—SLC22A11—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.00014	0.0022	CbGpPWpGaD
Ketoprofen—PTGS1—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.00014	0.0022	CbGpPWpGaD
Ketoprofen—PTGS1—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.00014	0.00219	CbGpPWpGaD
Ketoprofen—ALB—Vitamin B12 Metabolism—SERPINE1—focal segmental glomerulosclerosis	0.000139	0.00218	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—TGFB1—focal segmental glomerulosclerosis	0.000139	0.00218	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000137	0.00215	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet degranulation—TGFB1—focal segmental glomerulosclerosis	0.000135	0.00212	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000129	0.00203	CbGpPWpGaD
Ketoprofen—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—focal segmental glomerulosclerosis	0.000129	0.00202	CbGpPWpGaD
Ketoprofen—SLC22A7—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000127	0.002	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	0.000127	0.00199	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000125	0.00196	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00012	0.00188	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.000119	0.00186	CbGpPWpGaD
Ketoprofen—ALB—Platelet degranulation—FN1—focal segmental glomerulosclerosis	0.000117	0.00183	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	0.000114	0.00179	CbGpPWpGaD
Ketoprofen—SLC22A11—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	0.000114	0.00179	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000114	0.00179	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000114	0.00178	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—SERPINE1—focal segmental glomerulosclerosis	0.000113	0.00178	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000113	0.00177	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.000112	0.00175	CbGpPWpGaD
Ketoprofen—PTGS2—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.000111	0.00174	CbGpPWpGaD
Ketoprofen—ALB—Response to elevated platelet cytosolic Ca2+—FN1—focal segmental glomerulosclerosis	0.000111	0.00174	CbGpPWpGaD
Ketoprofen—PTGS2—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.000111	0.00174	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00011	0.00172	CbGpPWpGaD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000107	0.00168	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	0.000104	0.00164	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	0.000104	0.00163	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000104	0.00162	CbGpPWpGaD
Ketoprofen—SLC22A7—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	0.000103	0.00162	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000103	0.00162	CbGpPWpGaD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000103	0.00161	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—ACE—focal segmental glomerulosclerosis	0.000101	0.00159	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—GNAQ—focal segmental glomerulosclerosis	9.91e-05	0.00155	CbGpPWpGaD
Ketoprofen—ALB—Platelet degranulation—SERPINE1—focal segmental glomerulosclerosis	9.71e-05	0.00152	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	9.57e-05	0.0015	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	9.51e-05	0.00149	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	9.51e-05	0.00149	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	9.51e-05	0.00149	CbGpPWpGaD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	9.51e-05	0.00149	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	9.5e-05	0.00149	CbGpPWpGaD
Ketoprofen—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—focal segmental glomerulosclerosis	9.25e-05	0.00145	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	9.11e-05	0.00143	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	9.07e-05	0.00142	CbGpPWpGaD
Ketoprofen—ALB—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	8.99e-05	0.00141	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	8.99e-05	0.00141	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	8.93e-05	0.0014	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	8.7e-05	0.00136	CbGpPWpGaD
Ketoprofen—SLC22A8—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	8.7e-05	0.00136	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	8.69e-05	0.00136	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	8.69e-05	0.00136	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	8.64e-05	0.00135	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	8.45e-05	0.00133	CbGpPWpGaD
Ketoprofen—ABCC4—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	8.37e-05	0.00131	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	8.26e-05	0.0013	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	8e-05	0.00125	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	7.84e-05	0.00123	CbGpPWpGaD
Ketoprofen—SLCO1A2—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	7.72e-05	0.00121	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	7.49e-05	0.00117	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	7.37e-05	0.00116	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	7.31e-05	0.00115	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	7.26e-05	0.00114	CbGpPWpGaD
Ketoprofen—SLC22A6—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	7.26e-05	0.00114	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.15e-05	0.00112	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	6.98e-05	0.00109	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	6.9e-05	0.00108	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.77e-05	0.00106	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	6.73e-05	0.00106	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	6.64e-05	0.00104	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	6.41e-05	0.001	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	6.29e-05	0.000986	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	6.22e-05	0.000976	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	6.2e-05	0.000973	CbGpPWpGaD
Ketoprofen—ALB—Platelet degranulation—TGFB1—focal segmental glomerulosclerosis	6.13e-05	0.000961	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.12e-05	0.00096	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	6.01e-05	0.000942	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—FN1—focal segmental glomerulosclerosis	5.89e-05	0.000924	CbGpPWpGaD
Ketoprofen—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—focal segmental glomerulosclerosis	5.84e-05	0.000916	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—NOS2—focal segmental glomerulosclerosis	5.82e-05	0.000913	CbGpPWpGaD
Ketoprofen—SLC22A11—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	5.8e-05	0.000909	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.65e-05	0.000887	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	5.63e-05	0.000883	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	5.55e-05	0.00087	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	5.48e-05	0.000859	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	5.38e-05	0.000844	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TRPC6—focal segmental glomerulosclerosis	5.37e-05	0.000841	CbGpPWpGaD
Ketoprofen—SLC22A7—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	5.26e-05	0.000825	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	5.17e-05	0.000812	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	5.15e-05	0.000807	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	5.13e-05	0.000805	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	5.1e-05	0.0008	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	5.06e-05	0.000794	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	5.03e-05	0.000789	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	5.02e-05	0.000787	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	4.9e-05	0.000769	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—ALB—focal segmental glomerulosclerosis	4.9e-05	0.000768	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	4.78e-05	0.00075	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.7e-05	0.000738	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	4.67e-05	0.000733	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	4.64e-05	0.000728	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	4.59e-05	0.00072	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—GNAQ—focal segmental glomerulosclerosis	4.48e-05	0.000703	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	4.46e-05	0.000699	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	4.43e-05	0.000695	CbGpPWpGaD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	4.42e-05	0.000693	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	4.31e-05	0.000675	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	4.29e-05	0.000673	CbGpPWpGaD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	4.24e-05	0.000665	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	4.13e-05	0.000647	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	4.12e-05	0.000646	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	4.09e-05	0.000642	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	4.04e-05	0.000634	CbGpPWpGaD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	3.92e-05	0.000616	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.92e-05	0.000615	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.8e-05	0.000595	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	3.78e-05	0.000592	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.72e-05	0.000584	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	3.69e-05	0.000579	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.63e-05	0.000569	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.6e-05	0.000565	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—LIPC—focal segmental glomerulosclerosis	3.49e-05	0.000547	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.33e-05	0.000522	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.25e-05	0.000509	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.23e-05	0.000506	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	3.14e-05	0.000492	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—TGFB1—focal segmental glomerulosclerosis	3.1e-05	0.000486	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.09e-05	0.000485	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CTGF—focal segmental glomerulosclerosis	3.07e-05	0.000482	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.07e-05	0.000482	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.06e-05	0.000479	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.97e-05	0.000466	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.83e-05	0.000444	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—LPL—focal segmental glomerulosclerosis	2.8e-05	0.000439	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—LIPC—focal segmental glomerulosclerosis	2.77e-05	0.000435	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.76e-05	0.000433	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	2.72e-05	0.000426	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—FN1—focal segmental glomerulosclerosis	2.67e-05	0.000418	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.64e-05	0.000415	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—NOS2—focal segmental glomerulosclerosis	2.64e-05	0.000413	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.63e-05	0.000412	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.55e-05	0.0004	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.51e-05	0.000394	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.49e-05	0.000391	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CTGF—focal segmental glomerulosclerosis	2.44e-05	0.000383	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—AGT—focal segmental glomerulosclerosis	2.4e-05	0.000376	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—LIPC—focal segmental glomerulosclerosis	2.25e-05	0.000354	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.25e-05	0.000353	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—LIPC—focal segmental glomerulosclerosis	2.24e-05	0.000352	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	2.22e-05	0.000348	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.15e-05	0.000337	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—LPL—focal segmental glomerulosclerosis	2.13e-05	0.000334	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.12e-05	0.000333	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.03e-05	0.000318	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—LPL—focal segmental glomerulosclerosis	2.02e-05	0.000317	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CTGF—focal segmental glomerulosclerosis	1.98e-05	0.000311	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CTGF—focal segmental glomerulosclerosis	1.97e-05	0.00031	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—ALB—focal segmental glomerulosclerosis	1.84e-05	0.000288	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	1.83e-05	0.000288	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.83e-05	0.000287	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—AGT—focal segmental glomerulosclerosis	1.82e-05	0.000286	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.82e-05	0.000285	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—LPL—focal segmental glomerulosclerosis	1.69e-05	0.000265	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.65e-05	0.000259	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.63e-05	0.000255	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	1.62e-05	0.000253	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NOS2—focal segmental glomerulosclerosis	1.58e-05	0.000247	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.49e-05	0.000233	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—AGT—focal segmental glomerulosclerosis	1.45e-05	0.000227	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TGFB1—focal segmental glomerulosclerosis	1.4e-05	0.00022	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—ALB—focal segmental glomerulosclerosis	1.4e-05	0.000219	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—LPL—focal segmental glomerulosclerosis	1.38e-05	0.000216	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—LPL—focal segmental glomerulosclerosis	1.37e-05	0.000215	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.34e-05	0.00021	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—SERPINE1—focal segmental glomerulosclerosis	1.33e-05	0.000208	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—AGT—focal segmental glomerulosclerosis	1.18e-05	0.000185	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—AGT—focal segmental glomerulosclerosis	1.17e-05	0.000184	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	1.12e-05	0.000176	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ALB—focal segmental glomerulosclerosis	1.11e-05	0.000174	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	9.58e-06	0.00015	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ALB—focal segmental glomerulosclerosis	9.03e-06	0.000142	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TGFB1—focal segmental glomerulosclerosis	8.38e-06	0.000131	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	7.35e-06	0.000115	CbGpPWpGaD
